AstraZeneca delivers positive update on blood disease drug

Retrieved on: 2021-07-26 06:11:15

Tags for this article:

Health sciences

Health

Pharmaceutical industry

Adenoviridae

Oxford–AstraZeneca COVID-19 vaccine

AstraZeneca

Paroxysmal nocturnal hemoglobinuria

European Medicines Agency

Paroxysmal attack

Marketing authorisation

Clinical trial

Ravulizumab

Click the tags to see associated articles and topics

AstraZeneca delivers positive update on blood disease drug. View article details on HISWAI: https://www.stockmarketwire.com/article/7210987/AstraZeneca-delivers-positive-update-on-blood-disease-drug.html

Excerpt

StockMarketWire.com - Pharmaceutical giant AstraZeneca said its drug to treat paroxysmal nocturnal haemoglobinuria, a rare blood disease, had ...

Article found on: www.stockmarketwire.com

View Original Article